Nan Li

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Magnetic Resonance

Monoclonal Antibody

Top Venues

Hepatology communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Aarti Kolluri, Dan Li, Nan Li, Zhijian Duan, Lewis Rowland Roberts, Mitchell Ho
Human VH-based chimeric antigen receptor T cells targeting glypican 3 eliminate tumors in preclinical models of HCC. Hepatology communications 7 (2) (2023)
Aarti Kolluri, Dan Li, Nan Li, Zhijian Duan, Lewis Rowland Roberts, Mitchell Ho
Human VH-based chimeric antigen receptor T cells targeting glypican 3 eliminate tumors in preclinical models of HCC. Hepatology communications 7 (2) (2023)
Aarti Kolluri, Dan Li, Nan Li, Zhijian Duan, Lewis Rowland Roberts, Mitchell Ho
Human VH-based chimeric antigen receptor T cells targeting glypican 3 eliminate tumors in preclinical models of HCC. Hepatology communications 7 (2) (2023)
Jiajia Pan, Nan Li, Alex Renn, Hu Zhu, Lu Chen, Min Shen, Matthew D Hall, Min Qian, Ira H Pastan, Mitchell Ho
GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt Signaling. Molecular cancer therapeutics 21 (6) (2022)
Sakshi Tomar, Jingli Zhang, Manakamana Khanal, Jessica Hong, Abhilash Venugopalan, Qun Jiang, Manjistha Sengupta, Markku M Miettinen, Nan Li, Ira H Pastan, Mitchell Ho, Raffit Hassan
Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors. Molecular cancer therapeutics 21 (7) (2022)